contrast media injetion
Innovating Cancer Care: Bayer’s Low-Dose Contrast Enhanced MRI
Advancing radiology for smart imaging
Bracco at ECR 2025: Innovations in Contrast Media and Sustainability
Bracco brings actionable solutions for ‘Planet Radiology’ to ECR 2025
Bayer at ECR 2025: Shaping Radiology with Contrast & AI
Positive results from Phase III study for Bayer’s investigational contrast agent gadoquatrane
SIRM2024: Bracco on New Contrast & Trends in EMEA
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.
